| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 33929 |
| 1 | PREDNISONE | 21482 |
| 2 | METHOTREXATE SODIUM | 16716 |
| 3 | METHOTREXATE | 15179 |
| 4 | INFLIXIMAB | 14910 |
| 5 | ETANERCEPT | 14674 |
| 6 | ACETAMINOPHEN | 12129 |
| 7 | RITUXIMAB | 11472 |
| 8 | ERGOCALCIFEROL | 10481 |
| 9 | GABAPENTIN | 9858 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMADACYCLINE | 138 | 0.5267 |
| 1 | IVOSIDENIB | 550 | 0.5116 |
| 2 | INFLIXIMAB-DYYB | 4839 | 0.4739 |
| 3 | RITUXIMAB-ABBS | 661 | 0.4202 |
| 4 | PRASTERONE | 482 | 0.3850 |
| 5 | ISAVUCONAZONIUM SULFATE | 627 | 0.3466 |
| 6 | PURIXAN | 178 | 0.3213 |
| 7 | BECAPLERMIN | 671 | 0.3194 |
| 8 | DEFIBROTIDE SODIUM | 522 | 0.2705 |
| 9 | ANAKINRA | 2562 | 0.2613 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 48036 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 35080 |
| 2 | RANK Ligand Inhibitor [EPC] | 33929 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26254 |
| 4 | Atypical Antipsychotic [EPC] | 18197 |
| 5 | Kinase Inhibitor [EPC] | 18181 |
| 6 | Benzodiazepine [EPC] | 16896 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 15291 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 15142 |
| 9 | Anti-epileptic Agent [EPC] | 14484 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Antithrombin [EPC] | 7 | 0.4375 |
| 1 | Antileishmanial [EPC] | 65 | 0.3202 |
| 2 | Human Platelet-derived Growth Factor [EPC] | 671 | 0.3194 |
| 3 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 123 | 0.3060 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 2562 | 0.2613 |
| 5 | Interferon gamma Blocker [EPC] | 9 | 0.2195 |
| 6 | RANK Ligand Inhibitor [EPC] | 33929 | 0.2181 |
| 7 | Lipoglycopeptide Antibacterial [EPC] | 152 | 0.2120 |
| 8 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 182 | 0.2061 |
| 9 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |